Critically ill patients: Immunological evidence of inflammation in muscle biopsy

P. Bazzi, M. Moggio, A. Prelle, M. Sciacco, S. Messina, S. Barbieri, P. Tonin, G. Tomelleri, A. Battistel, L. Adobbati, N. Checcarelli, G. Veschi, G. Scarlato

Research output: Contribution to journalArticle

Abstract

Aim and method: To verify whether muscle necrosis in critically ill patients could be due to an inflammatory process, we tested muscle biopsies from five intensive care patients with different inflammation-specific immunocytochemical markers (antibodies anti-class I major histocompatibility complex products (class I MHCP or HLA I), membrane attack complex (MAC), T lymphocytes helper-inducer (CD4), cytotoxic (CD8) and pan-B-lymphocytes). Results: In three patients muscle biopsy showed class I MHCP positivity on the surface membrane of several groups of fibres, mainly perifascicular, and scattered microvascular deposits of MAC. In the other two patients muscle biopsy did not show class I MHCP and MAC positivity. Conclusion: Our results suggest that inflammation may be a component of muscle damage in some critically ill patients.

Original languageEnglish
Pages (from-to)23-30
Number of pages8
JournalClinical Neuropathology
Volume18
Issue number1
Publication statusPublished - Jan 1999

Fingerprint

Critical Illness
Complement Membrane Attack Complex
Inflammation
Biopsy
Muscles
Immunoglobulin Isotypes
Critical Care
Helper-Inducer T-Lymphocytes
Major Histocompatibility Complex
B-Lymphocytes
Necrosis
Membranes

Keywords

  • Critical illness myopathy
  • Inflammation
  • Intensive care patients
  • Septic syndrome

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Bazzi, P., Moggio, M., Prelle, A., Sciacco, M., Messina, S., Barbieri, S., ... Scarlato, G. (1999). Critically ill patients: Immunological evidence of inflammation in muscle biopsy. Clinical Neuropathology, 18(1), 23-30.

Critically ill patients : Immunological evidence of inflammation in muscle biopsy. / Bazzi, P.; Moggio, M.; Prelle, A.; Sciacco, M.; Messina, S.; Barbieri, S.; Tonin, P.; Tomelleri, G.; Battistel, A.; Adobbati, L.; Checcarelli, N.; Veschi, G.; Scarlato, G.

In: Clinical Neuropathology, Vol. 18, No. 1, 01.1999, p. 23-30.

Research output: Contribution to journalArticle

Bazzi, P, Moggio, M, Prelle, A, Sciacco, M, Messina, S, Barbieri, S, Tonin, P, Tomelleri, G, Battistel, A, Adobbati, L, Checcarelli, N, Veschi, G & Scarlato, G 1999, 'Critically ill patients: Immunological evidence of inflammation in muscle biopsy', Clinical Neuropathology, vol. 18, no. 1, pp. 23-30.
Bazzi, P. ; Moggio, M. ; Prelle, A. ; Sciacco, M. ; Messina, S. ; Barbieri, S. ; Tonin, P. ; Tomelleri, G. ; Battistel, A. ; Adobbati, L. ; Checcarelli, N. ; Veschi, G. ; Scarlato, G. / Critically ill patients : Immunological evidence of inflammation in muscle biopsy. In: Clinical Neuropathology. 1999 ; Vol. 18, No. 1. pp. 23-30.
@article{401d54755c124cc9bf5328a1c0d704ff,
title = "Critically ill patients: Immunological evidence of inflammation in muscle biopsy",
abstract = "Aim and method: To verify whether muscle necrosis in critically ill patients could be due to an inflammatory process, we tested muscle biopsies from five intensive care patients with different inflammation-specific immunocytochemical markers (antibodies anti-class I major histocompatibility complex products (class I MHCP or HLA I), membrane attack complex (MAC), T lymphocytes helper-inducer (CD4), cytotoxic (CD8) and pan-B-lymphocytes). Results: In three patients muscle biopsy showed class I MHCP positivity on the surface membrane of several groups of fibres, mainly perifascicular, and scattered microvascular deposits of MAC. In the other two patients muscle biopsy did not show class I MHCP and MAC positivity. Conclusion: Our results suggest that inflammation may be a component of muscle damage in some critically ill patients.",
keywords = "Critical illness myopathy, Inflammation, Intensive care patients, Septic syndrome",
author = "P. Bazzi and M. Moggio and A. Prelle and M. Sciacco and S. Messina and S. Barbieri and P. Tonin and G. Tomelleri and A. Battistel and L. Adobbati and N. Checcarelli and G. Veschi and G. Scarlato",
year = "1999",
month = "1",
language = "English",
volume = "18",
pages = "23--30",
journal = "Clinical Neuropathology",
issn = "0722-5091",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "1",

}

TY - JOUR

T1 - Critically ill patients

T2 - Immunological evidence of inflammation in muscle biopsy

AU - Bazzi, P.

AU - Moggio, M.

AU - Prelle, A.

AU - Sciacco, M.

AU - Messina, S.

AU - Barbieri, S.

AU - Tonin, P.

AU - Tomelleri, G.

AU - Battistel, A.

AU - Adobbati, L.

AU - Checcarelli, N.

AU - Veschi, G.

AU - Scarlato, G.

PY - 1999/1

Y1 - 1999/1

N2 - Aim and method: To verify whether muscle necrosis in critically ill patients could be due to an inflammatory process, we tested muscle biopsies from five intensive care patients with different inflammation-specific immunocytochemical markers (antibodies anti-class I major histocompatibility complex products (class I MHCP or HLA I), membrane attack complex (MAC), T lymphocytes helper-inducer (CD4), cytotoxic (CD8) and pan-B-lymphocytes). Results: In three patients muscle biopsy showed class I MHCP positivity on the surface membrane of several groups of fibres, mainly perifascicular, and scattered microvascular deposits of MAC. In the other two patients muscle biopsy did not show class I MHCP and MAC positivity. Conclusion: Our results suggest that inflammation may be a component of muscle damage in some critically ill patients.

AB - Aim and method: To verify whether muscle necrosis in critically ill patients could be due to an inflammatory process, we tested muscle biopsies from five intensive care patients with different inflammation-specific immunocytochemical markers (antibodies anti-class I major histocompatibility complex products (class I MHCP or HLA I), membrane attack complex (MAC), T lymphocytes helper-inducer (CD4), cytotoxic (CD8) and pan-B-lymphocytes). Results: In three patients muscle biopsy showed class I MHCP positivity on the surface membrane of several groups of fibres, mainly perifascicular, and scattered microvascular deposits of MAC. In the other two patients muscle biopsy did not show class I MHCP and MAC positivity. Conclusion: Our results suggest that inflammation may be a component of muscle damage in some critically ill patients.

KW - Critical illness myopathy

KW - Inflammation

KW - Intensive care patients

KW - Septic syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032938728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032938728&partnerID=8YFLogxK

M3 - Article

C2 - 9988135

AN - SCOPUS:0032938728

VL - 18

SP - 23

EP - 30

JO - Clinical Neuropathology

JF - Clinical Neuropathology

SN - 0722-5091

IS - 1

ER -